Minerva Neuroscie (NERV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NERV | PRLD | IKT | ||
| Company | Minerva Neuroscie | Prelude Therapeutics Inc | Inhibikase Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 4.09 | 2.81 | 1.98 | ||
| High | 4.21 | 2.95 | 2.06 | ||
| Low | 3.94 | 2.75 | 1.94 | ||
| Latest | 4.02 | 2.90 | 2.05 | ||
| Change | -0.04 | +0.06 | +0.08 | ||
| % Change | -0.99% | +2.11% | +4.06% | ||
| Volume | 69,100 | 219,200 | 506,400 | ||
| 20-Day Average Volume | 40,395 | 488,530 | 631,440 | ||
| Previous Close | 4.06 | 2.84 | 1.97 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 3.94 | 2.01 | 1.65 | ||
| 20-Day Raw Stochastic | 77.00% | 94.13% | 86.68% | ||
| 20-Day Relative Strength | 52.60 | 67.73 | 67.77 | ||
| Weighted Alpha | +22.49 | +67.87 | -23.66 | ||
| Today's Opinion | 72% Buy | 100% Buy | 24% Buy | ||
| Previous Opinion | 88% Buy | 100% Buy | 16% Buy | ||
| Last Month's Opinion | 88% Buy | 80% Buy | 96% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.99% since 12/23/25 | +32.42% since 12/23/25 | +28.93% since 12/23/25 | ||
| Low | 3.90 on 12/30/25 | 2.20 on 12/24/25 | 1.58 on 12/24/25 | ||
| High | 4.24 on 12/30/25 | 3.00 on 12/29/25 | 2.15 on 12/29/25 | ||
| 1-Month | |||||
| %Chg | -3.83% since 11/28/25 | +72.62% since 11/28/25 | +34.87% since 11/28/25 | ||
| Low | 3.25 on 12/03/25 | 1.29 on 12/03/25 | 1.40 on 12/03/25 | ||
| High | 4.25 on 12/16/25 | 3.00 on 12/29/25 | 2.15 on 12/29/25 | ||
| 3-Month | |||||
| %Chg | +90.97% since 09/30/25 | +101.39% since 09/30/25 | +26.54% since 09/30/25 | ||
| Low | 2.06 on 10/01/25 | 1.15 on 10/10/25 | 1.33 on 11/03/25 | ||
| High | 12.46 on 10/21/25 | 4.22 on 11/03/25 | 2.15 on 12/29/25 | ||
| 6-Month | |||||
| %Chg | +133.72% since 06/30/25 | +258.29% since 06/30/25 | +5.13% since 06/30/25 | ||
| Low | 1.57 on 07/01/25 | 0.75 on 08/12/25 | 1.33 on 11/03/25 | ||
| High | 12.46 on 10/21/25 | 4.22 on 11/03/25 | 2.15 on 12/29/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 173,961 | 182,309 | 154,109 | ||
| Shares Outstanding, K | 43,274 | 62,865 | 75,175 | ||
| Annual Sales | 0 | 7,000,000 | 0 | ||
| Annual Net Income | 1,440,000 | -127,170,000 | -27,520,000 | ||
| Last Quarter Sales | 0 | 6,500,000 | 0 | ||
| Last Quarter Net Income | -2,740,000 | -19,730,000 | -11,930,000 | ||
| 60-Month Beta | -0.40 | 1.06 | 0.88 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.36 on 11/05/25 | -0.26 on 11/12/25 | -0.13 on 11/14/25 | ||
| Latest Earnings Date | 02/24/26 | 03/09/26 | 03/26/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||